Biosimilar Competition. The royalty rate under Sections 6.3(a) shall be reduced by [****] percent ([****]%), on a country-by-country basis and Product-by-Product basis, in each country in which Biosimilar Competition exists with respect to such Product in a country of the Territory.
Appears in 4 contracts
Samples: License Agreement, License Agreement (Provention Bio, Inc.), License Agreement (Provention Bio, Inc.)
